Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis.

Kozak I, Vaidya V, Van Natta ML, Pak JW, May KP, Thorne JE; Studies of the Ocular Complications of AIDS Research Group.

Invest Ophthalmol Vis Sci. 2014 Jun 12;55(7):4304-12. doi: 10.1167/iovs.14-14479.

PMID:
24925880
[PubMed - in process]
2.

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

Fierer DS, Dieterich DT, Mullen MP, Branch AD, Uriel AJ, Carriero DC, van Seggelen WO, Hijdra RM, Cassagnol DG; New York Acute Hepatitis C Surveillance Network.

Clin Infect Dis. 2014 Mar;58(6):873-9. doi: 10.1093/cid/cit799. Epub 2013 Dec 13.

PMID:
24336914
[PubMed - in process]
3.

Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.

Jabs DA, Ahuja A, Van Natta M, Dunn JP, Yeh S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2013 Jun;120(6):1262-70. doi: 10.1016/j.ophtha.2012.11.023. Epub 2013 Feb 16.

PMID:
23419804
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.

Gangaputra S, Drye L, Vaidya V, Thorne JE, Jabs DA, Lyon AT; Studies of the Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2013 Feb;155(2):206-212.e5. doi: 10.1016/j.ajo.2012.07.019. Epub 2012 Oct 12.

PMID:
23068916
[PubMed - indexed for MEDLINE]
5.

Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.

Inker LA, Wyatt C, Creamer R, Hellinger J, Hotta M, Leppo M, Levey AS, Okparavero A, Graham H, Savage K, Schmid CH, Tighiouart H, Wallach F, Krishnasami Z.

J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):302-9. doi: 10.1097/QAI.0b013e31826a6c4f.

PMID:
22842844
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2012 Jun;153(6):1016-24.e5. doi: 10.1016/j.ajo.2011.11.014. Epub 2012 Feb 4.

PMID:
22310076
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.

Holbrook JT, Colvin R, van Natta ML, Thorne JE, Bardsley M, Jabs DA; Studies of Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2011 Oct;152(4):628-637.e1. doi: 10.1016/j.ajo.2011.04.007. Epub 2011 Jul 13.

PMID:
21742304
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.

Sezgin E, van Natta ML, Ahuja A, Lyon A, Srivastava S, Troyer JL, O'Brien SJ, Jabs DA; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2011 Jun;151(6):999-1006.e4. doi: 10.1016/j.ajo.2010.11.029. Epub 2011 Mar 10.

PMID:
21396623
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Barriers to HIV care: an exploration of the complexities that influence engagement in and utilization of treatment.

Cavaleri MA, Kalogerogiannis K, McKay MM, Vitale L, Levi E, Jones S, Wallach F, Flynn E.

Soc Work Health Care. 2010;49(10):934-45. doi: 10.1080/00981389.2010.514563.

PMID:
21113849
[PubMed - indexed for MEDLINE]
10.

Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.

Puhan MA, Van Natta ML, Palella FJ, Addessi A, Meinert C; Ocular Complications of AIDS Research Group.

Clin Infect Dis. 2010 Oct 15;51(8):947-56. doi: 10.1086/656415.

PMID:
20825306
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.

Jabs DA, Ahuja A, Van Natta M, Lyon A, Srivastava S, Gangaputra S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2010 Nov;117(11):2152-61.e1-2. doi: 10.1016/j.ophtha.2010.03.031. Epub 2010 Jul 29.

PMID:
20673591
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Healthcare-associated Infections: epidemiology, prevention, and therapy.

Doshi RK, Patel G, Mackay R, Wallach F.

Mt Sinai J Med. 2009 Feb;76(1):84-94. doi: 10.1002/msj.20070. Review.

PMID:
19170222
[PubMed - indexed for MEDLINE]
13.

[Free dermal fat graft for coverage of the median nerve following failed carpal tunnel release].

Wallach F, Richou J, Genestet M, Le Nen D.

Chir Main. 2008 Oct;27(5):208-15. doi: 10.1016/j.main.2008.08.011. Epub 2008 Sep 26. French.

PMID:
18930427
[PubMed - indexed for MEDLINE]
14.

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AI, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, Bellos N, Saag M, Cooper DA, Westby M, Tawadrous M, Sullivan JF, Ridgway C, Dunne MW, Felstead S, Mayer H, van der Ryst E; MOTIVATE 1 and MOTIVATE 2 Study Teams.

N Engl J Med. 2008 Oct 2;359(14):1442-55. doi: 10.1056/NEJMoa0803154.

PMID:
18832245
[PubMed - indexed for MEDLINE]
Free Article
15.

Maraviroc for previously treated patients with R5 HIV-1 infection.

Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H; MOTIVATE Study Teams.

N Engl J Med. 2008 Oct 2;359(14):1429-41. doi: 10.1056/NEJMoa0803152.

PMID:
18832244
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Acceptance of rapid HIV testing among medical inpatients in New York City.

Jain CL, Jue JS, MacKay R, Wallach F, Factor SH, Wyatt CM.

AIDS Patient Care STDS. 2008 Aug;22(8):657-62. doi: 10.1089/apc.2007.0189.

PMID:
18721054
[PubMed - indexed for MEDLINE]
17.

Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals.

Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, Sacks H.

Int J Tuberc Lung Dis. 2007 Nov;11(11):1190-5.

PMID:
17958980
[PubMed - indexed for MEDLINE]
18.

[Endoscopic treatment of snapping scapula].

Desmoineaux P, Wallach F, Jouve F, Boisrenoult P.

Chir Main. 2006 Nov;25 Suppl 1:S91-5. Review. French.

PMID:
17361877
[PubMed - indexed for MEDLINE]
19.

[Endoscopic treatment of snapping scapula.]

Desmoineaux P, Wallach F, Jouve F, Boisrenoult P.

Chir Main. 2006 Nov;25S1:S91-S95. Epub 2006 Aug 4. French.

PMID:
17349417
[PubMed - as supplied by publisher]
20.

Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA.

Cara A, Vargas J Jr, Keller M, Jones S, Mosoian A, Gurtman A, Cohen A, Parkas V, Wallach F, Chusid E, Gelman IH, Klotman ME.

Virology. 2002 Jan 5;292(1):1-5.

PMID:
11878902
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk